This is a preview of subscription content, log in via an institution to check access.
Literature Cited
L. G. Artemova, T. I. Torkhovskaya, B. G. Khodzhakuliev, et al., Byull. Éksp. Biol. Med., No. 8, 230 (1984).
E. A. Borodin, M. É. Lanio, S. S. Markin, et al., Vopr. Med. Khimii, No. 2, 75 (1984).
A. N. Klimov, Proceedings of the 4th All-Union Congress of Cardiologists [in Russian], Moscow (1986), p. 13.
T. I. Torkhovskaya, E. A. Gorbatenkova, V. A. Dudaev, et al., Vopr. Med. Khimii, No. 2, 101 (1986).
M. Bartholome, M. E. Baulet, B. Lassere, and B. Jacott, Biochim. Biophys. Acta,664, 327 (1981).
S. Eisenberg, J. Lipid Res.,25, 1015 (1984).
J. Schneider, Therapeutic Selectivity and Risk Benefit Assessment of Hypolipidemic Drugs, ed. by G. Ricci et al., New York (1982), p. 263.
T. I. Torkhovskaya (T. J. Torchovskaya), E. M. Khalilov, and A. J. Archakov (A. I. Archakov), Human Atherosclerosis, Vol. 2, London (1986), pp. 129–148.
K. J. Williams and A. M. Scanu, Biochim. Biophys. Acta,875, 183 (1986).
O. Zierenberg, Phospholipids and Atherosclerosis, New York (1983), pp. 175–190.
Rights and permissions
About this article
Cite this article
Khalilov, É.M., Torkhovskaya, T.I., Fortinskaya, E.S. et al. Possible approaches to the use of phospholipid preparations as membrane cholesterol receptors. Bull Exp Biol Med 107, 510–512 (1989). https://doi.org/10.1007/BF00842392
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00842392